Topical probiotics for reducing infections by multidrug resistant bacteria

Project Overview

Our client, Dr. Nasia Safdar, of the UW-Madison Department of Medicine, researches the use of probiotics. Currently, she is researching the efficiency of the probiotic lactobacillus GG in preventing staphylococcus aureus infections when the probiotics are applied to the interior nasal passage. A device to deliver the probiotic to the inside of the nose is needed to perform clinical trials with the probiotic. The delivery device should allow the accurate delivery of one billion viable lactobacillus GG organisms to the nose. Also, a solution in which to suspend and deliver the bacteria to the nose needs to be found. The lactobacillus GG should live inside the nasal passage for at least one day to allow for daily application of the probiotic.

Team Picture

Team Photo. From right to left: Courtney, Wan-Ting(Jessica), Kimberli, and Albert

Files

Poster (April 29, 2011)
Product Design Specification (May 3, 2011)
Final Report (May 3, 2011)
Midsemester Presentation Slides (March 3, 2011)
Mid-Semester Report (March 8, 2011)

Contact Information

Team Members

Kimberli Carlson - Team Leader
Wan-Ting Kou - Communicator
Courtney Krueger - BSAC
Albert Wang - BWIG

Advisor and Client

Prof. John Puccinelli - Advisor
Nasia Safdar - Client